Natera

Bioinformatician

United States

Not SpecifiedCompensation
Junior (1 to 2 years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, Genomics, HealthcareIndustries

Position Overview

  • Location Type: Remote USA
  • Job Type: Full-time
  • Salary: $101,800 - $127,300 USD

Natera™ is seeking a Bioinformatician with immunology experience to join a multidisciplinary team developing leading-edge genomics analysis tools to understand the immune system's response to cancer. This self-motivated, detail-oriented individual will join the Therapeutics and Innovations group and will be responsible for developing and applying bioinformatics methods to immuno-oncology clinical datasets, creating descriptive summary statistics and data visualizations, and technical reports.

Requirements

  • Great understanding of immunology and human genetics (understanding of oncology is preferred).
  • Experience analyzing genomic sequencing data from Illumina platforms.
  • Experience analyzing long-read nucleic acid datasets such as PacBio or Oxford Nanopore.
  • Experience analyzing high-throughput RNA-seq data.
  • Familiarity with using and scripting in UNIX shell (e.g., Bash).
  • Strong programming skills in common bioinformatics scripting languages (e.g., Python, R).
  • Ability to collaborate and communicate with other scientists, researchers, and clinicians.
  • Demonstrated project management skills and ability to produce readable, reproducible, and documented code (e.g., Jupyter, R markdown, etc.).
  • Strong team-oriented work ethic with open, honest, and considerate communication skills.
  • Immune repertoire analysis experience is a plus (e.g., Immcantation, MiXCR, TRUST4, immunarch, etc.).
  • Experience writing SQL queries for data retrieval is required is a plus.
  • Exposure to cancer genomics somatic variant calling is a plus.
  • Experience working with large external data sources such as IEDB, iReceptor, VDJdb, and others is a plus.

Responsibilities

  • With the assistance of a multidisciplinary team, develop or enhance computational tools to predict antigenic somatic variants.
  • Assist bioinformaticians and data scientists in developing approaches to gain better understanding of T-cell receptor binding to MHC-peptide complexes.
  • Use internal and external genomics data sources to understand how somatic and germline variation impacts the immune system’s response to cancer.
  • Run and enhance established immune repertoire sequencing pipelines and workflows for NGS analysis in a clinical setting.
  • Prototype, develop, document, deploy, and support novel clinical DNA and RNA sequencing analysis approaches for NGS analysis.
  • Benchmark new tools for sequencing data analysis and propose improvements.
  • Develop QC metrics, gold standard datasets and tools for systematically testing and evaluating the accuracy of newly developed assays and methods.
  • Collaborate with technical teams in specifying requirements for tools to enhance workflow efficiency, turnaround times and robustness.
  • Participate in internal research projects and external research collaborations.
  • Assist in preparing text and figures for manuscripts and external presentations.
  • Summarize results in written or oral reports for computational biologists, molecular biologists, clinicians, and internal researchers.

Education/Experience

  • PhD degree in bioinformatics, computational biology, statistics, immunology, or a related field; OR
  • MS degree with 3+ years of post-graduation experience in bioinformatics, biology, computational biology, statistics, immunology, or a related field.

Company Information

Natera™ is a global leader in cell-free DNA (cfDNA) testing, dedicated to oncology, women’s health, and organ health. Our aim is to make personalized genetic testing and diagnostics part of the standard of care.

#LI-TH1 #LI-Remote

Skills

Genomics
Bioinformatics
Immunology
NGS analysis
Data visualization
Statistical analysis
Clinical datasets
T-cell receptor binding
Sequencing pipelines
DNA/RNA sequencing

Natera

Genetic testing and diagnostics solutions provider

About Natera

Natera focuses on genetic testing and diagnostics, providing advanced solutions for cancer patients, transplant patients, and individuals assessing hereditary health risks. Their main technology is cell-free DNA (cfDNA) testing, which analyzes DNA fragments in the blood to detect minimal traces of cancer and assess organ health. Natera stands out by offering specialized tests like the Signatera ctDNA test and Panorama NIPT, along with genetic counseling services. The company's goal is to improve patient care and health outcomes through accurate genetic testing.

Austin, TexasHeadquarters
2004Year Founded
$149.9MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
1,001-5,000Employees

Benefits

Flexible medical plans
Investment options
Time off
Workplace perks

Risks

Hindenburg report accuses Natera of deceptive sales practices, risking legal challenges.
New Prospera Heart features may face slow adoption by healthcare providers.
Fetal RhD NIPT demand may drop post-RhIg shortage, affecting future sales.

Differentiation

Natera's Signatera test offers personalized ctDNA analysis for cancer patients.
Prospera Heart test uses unique Donor Quantity Score for transplant rejection detection.
Panorama NIPT test is a leader in non-invasive prenatal testing with 2 million tests.

Upsides

Increased adoption of liquid biopsy techniques boosts demand for Natera's cfDNA tests.
AI integration enhances accuracy and speed of Natera's cfDNA analysis.
Growing personalized medicine trend aligns with Natera's customized genetic tests.

Land your dream remote job 3x faster with AI